Fundraising Fox

Cardiac Insight Inc.

Bellevue, US · 4 known investors

Cardiac Insight develops handheld and wearable ECG devices for cardiac diagnostics, including the Cardea 20/20 for athlete heart screening and the Cardea SOLO for 7-day ambulatory monitoring. The company serves healthcare providers and patients seeking reliable electrocardiogram analysis and cardiac evaluation.

BiotechHardwareHealthtechMedical Devices

Founders & leadership

DL
David LinkerCo-founder
DD
Dr. Dave HadleyFounder
DV
Dr. Vic FroelicherFounder
BW
Bill WillisExecutive
BH
Brad HarlowExecutive
RD
Robert deGavreExecutive
MS
Mike SchuhExecutive
BO
Bob OdellExecutive

Board

TCTom Clement
Tom ClementBoard directorMedical Device Executive and former Chairman of WBBA at The W Fund
LG
Lex GambleBoard director
HR
Hemanth ReddyBoard director
RM
Richard MartinBoard director

Investors · 4

Cowles VenturesSpokane · $250K – $1M
Keiretsu ForumSan Francisco · $250K – $2M
SeaChange$250K – $1M
The W FundSeattle · $500K

Reported raises · per SEC filings

Form D private placements

$35.3M disclosed across 8 rounds · 2014–2022

▶$11.6MraisedMar 2022 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Hyoung Min KimExecutive Officer, Director
  • Michael SchuhExecutive Officer
  • Robert OdellExecutive Officer
  • Ann DemareeExecutive Officer
  • David HadleyExecutive Officer
  • Daniel TylutkiExecutive Officer
  • Stacy SprouseExecutive Officer
  • Kurt NoltensmeyerExecutive Officer
Offering amount
$12.1M
Amount sold
$11.6M
Minimum investment
$20K
First sale
Mar 2022
Incorporated
Corporation, Washington
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.7MraisedAug 2019 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard MartinDirector
  • Bob OdellExecutive Officer
  • Mike SchuhExecutive Officer
  • Brad HarlowExecutive Officer, Director
  • Kirby CramerDirector
  • Robert deGavreDirector
  • Clifford StocksDirector
Offering amount
$11.8M
Amount sold
$4.7M
First sale
Jul 2019
Incorporated
Corporation, Washington
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.8MraisedAug 2017 · 31 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert deGavreDirector
  • Bob OdellExecutive Officer
  • Kirby CramerDirector
  • Mike SchuhExecutive Officer
  • Tom ClementDirector
  • Brad HarlowExecutive Officer, Director
  • Robert HauserDirector
  • Richard MartinDirector
  • Lex GambleDirector
  • Bill WillisExecutive Officer
Offering amount
$10M
Amount sold
$2.8M
First sale
May 2017
Incorporated
Corporation, Washington
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1MraisedDec 2016 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David LinkerExecutive Officer, Director
  • Brad HarlowExecutive Officer, Director
  • Lex GambleDirector
  • Kirby CramerDirector
  • Tom ClementDirector
  • Bob OdellExecutive Officer
  • Bill WillisExecutive Officer
  • Mike SchuhExecutive Officer
  • Hemanth ReddyDirector
  • Robert deGavreDirector
  • Richard MartinDirector
  • Robert HauserDirector
Offering amount
$2.4M
Amount sold
$1M
First sale
Nov 2016
Incorporated
Corporation, Washington
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.5MraisedApr 2016 · 30 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David LinkerExecutive Officer, Director
  • Mike SchuhExecutive Officer
  • Kirby CramerDirector
  • Bob OdellExecutive Officer
  • Hemanth ReddyDirector
  • Robert deGavreDirector
  • Tom ClementDirector
  • Richard MartinDirector
  • Robert HauserDirector
  • Brad HarlowExecutive Officer, Director
  • Lex GambleDirector
  • Bill WillisExecutive Officer
Offering amount
$5M
Amount sold
$2.5M
First sale
Apr 2016
Incorporated
Corporation, Washington
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.5MraisedSep 2015 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Bill WillisExecutive Officer
  • Hemanth ReddyDirector
  • Tom ClementDirector
  • Brad HarlowExecutive Officer, Director
  • Richard MartinDirector
  • Robert deGavreExecutive Officer, Director
  • David LinkerExecutive Officer, Director
  • Lex GambleDirector
  • Mike SchuhExecutive Officer
  • Bob OdellExecutive Officer
  • Robert HauserDirector
  • Kirby CramerDirector
Offering amount
$3.5M
Amount sold
$3.5M
First sale
Sep 2015
Incorporated
Corporation, Washington
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.1MraisedJul 2014 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mike SchuhExecutive Officer
  • David LinkerExecutive Officer, Director
  • Bob OdellExecutive Officer
  • Richard MartinDirector
  • Robert deGavreExecutive Officer, Director
  • Kirby CramerDirector
  • Bill WillisExecutive Officer
  • Lex GambleDirector
  • Robert HauserDirector
  • Tom ClementDirector
  • Brad HarlowExecutive Officer, Director
Offering amount
$9.1M
Amount sold
$7.1M
First sale
Jun 2014
Incorporated
Corporation, Washington
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedJan 2014 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Bill WillisExecutive Officer
  • Robert deGavreExecutive Officer, Director
  • Richard MartinDirector
  • Mike SchuhExecutive Officer
  • Brad HarlowExecutive Officer, Director
  • Robert HauserDirector
  • David LinkerExecutive Officer, Director
  • Lex GambleDirector
  • Kirby CramerDirector
  • Tom ClementDirector
  • Bob OdellExecutive Officer
Offering amount
$2M
Amount sold
$2M
First sale
Jan 2014
Incorporated
Corporation, Washington
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap
Rf Surgical49 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Boston Scientific42 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.

Companies competing with Cardiac Insight Inc. for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Cardiac Insight Inc. do?
Cardiac Insight develops handheld and wearable ECG devices for cardiac diagnostics, including the Cardea 20/20 for athlete heart screening and the Cardea SOLO for 7-day ambulatory monitoring. The company serves healthcare providers and patients seeking reliable electrocardiogram analysis and cardiac evaluation.
Who founded Cardiac Insight Inc.?
Cardiac Insight Inc. was founded by David Linker, Dr. Dave Hadley, Dr. Vic Froelicher.
Who are Cardiac Insight Inc.'s investors?
Cardiac Insight Inc.'s investors include Cowles Ventures, Keiretsu Forum, SeaChange, The W Fund.
How much funding has Cardiac Insight Inc. raised?
Cardiac Insight Inc. has disclosed $35.3M raised across 8 rounds.
Where is Cardiac Insight Inc. headquartered?
Cardiac Insight Inc. is headquartered in Bellevue, US.